drugset
drugset / Trial / NCT01372761

Pharmacokinetics, Safety, Tolerability and Efficacy of Intravenous Doses of ZGN-433 in Obese Female Volunteers

NCT01372761 ↗

Phase 1 Completed 25 enrolled Zafgen, Inc.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to assess whether multiple doses of ZGN-433 are safe and effective.

Timeline

Start
2011-06
Primary completion
2011-11
Completion
2011-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Beloranib Small molecule — Intravenous

Indications

obesity disorder